-
Rozanolixizumab/Rystiggo Treatment
Rozanolixizumab, brand name Rystiggo, was approved by the FDA last summer as a treatment for those with generalized Myasthenia gravis and anti-AChR or anti-MuSK antibodies. It is distributed with an under-the-skin infusion with an infusion pump once a week for six weeks, possibly more. https://myastheniagravisnews.com/news/fda-approves-rozanolixizumab-rystiggo-treat-gmg/
Have you started Rozanolixizumab/Rystiggo? Have you noticed any improvement or worsening of your symptoms? Any side effects?
Have you been talking to your doctor about starting this treatment in the future? What possible concerns do you have about it?
-
1 Reply
-
I was in an 18 week study in which we were testing manual and automatic delivery methods for delivery of the rosanolixizumab. I found the treatment very helpful. I had much more energy physically and mentally and generally felt better.
However, it totally tanked my immune numbers. At one point my IGg level was in the 90s; normal is 565 to 1700. We had to skip an infusion and when my IGg came up we started again. We did that a couple times.
I thought the drug provided a great treatment, except for the immune ramifications. So if you try it, make sure that you have regular check ups on your immune numbers. We checked mine every week.
Good luck! Love and Light,
Frank
Log in to reply.